A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination.
Journal article
Jones E. et al, (2021), Microorganisms, 9
Vi-specific serological correlates of protection for typhoid fever.
Journal article
Jin C. et al, (2021), The Journal of experimental medicine, 218
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
Journal article
Gibani MM. et al, (2020), PLoS Negl Trop Dis, 14
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.
Journal article
Gibani MM. et al, (2019), Nat Med, 25, 1082 - 1088
IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
Journal article
Dahora LC. et al, (2019), Front Immunol, 10
The impact of vaccination and prior exposure on stool shedding of salmonella typhi and salmonella paratyphi a in six controlled human infection studies
Journal article
GIBANI M. et al, (2018), Clinical Infectious Diseases
Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model
Journal article
Juel HB. et al, (2018), FRONTIERS IN IMMUNOLOGY, 8
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
Journal article
Jin C. et al, (2017), Lancet (London, England)
Natural and Vaccine-Mediated Immunity to Salmonella Typhimurium is Impaired by the Helminth Nippostrongylus brasiliensis
Journal article
Bobat S. et al, (2014), PLoS Neglected Tropical Diseases, 8